Source: Molecular Diagnosis and Therapy. Unidade: FCF
Subjects: ANTICOAGULANTES, DOENÇAS CARDIOVASCULARES, TROMBOSE
ABNT
HIRATA, Thiago Dominguez Crespo et al. Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients. Molecular Diagnosis and Therapy, v. 25, p. 735–755, 2021Tradução . . Disponível em: https://doi.org/10.1007/s40291-021-00549-z. Acesso em: 18 nov. 2024.APA
Hirata, T. D. C., Hernandez, C. D., Genvigir, F. D. V., Lauschke, V. M., Zhou, Y., Hirata, M. H., & Hirata, R. D. C. (2021). Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients. Molecular Diagnosis and Therapy, 25, 735–755. doi:10.1007/s40291-021-00549-zNLM
Hirata TDC, Hernandez CD, Genvigir FDV, Lauschke VM, Zhou Y, Hirata MH, Hirata RDC. Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients [Internet]. Molecular Diagnosis and Therapy. 2021 ; 25 735–755.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s40291-021-00549-zVancouver
Hirata TDC, Hernandez CD, Genvigir FDV, Lauschke VM, Zhou Y, Hirata MH, Hirata RDC. Cardiovascular pharmacogenomics: an update on clinical studies of antithrombotic drugs in Brazilian patients [Internet]. Molecular Diagnosis and Therapy. 2021 ; 25 735–755.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s40291-021-00549-z